In this video, Tom Lowe, director of Physicians Awareness UBI, and Kenneth J. Dillon, author of Healing Photons, discuss the history, science, challenges, and promise of Biophotonic Therapy. Also known as ultraviolet blood irradiation, BT treats small amounts of blood with light in extracorporeal or intravenous modes. BT was invented by Emmet Knott in the 1920s. Hundreds of clinical studies have shown its effectiveness in various indications, e.g., against childhood asthma. Thousands of practitioners around the world use it to treat a wide range of disorders. BT is the leading phototherapeutic treatment of infectious diseases.
Humankind needs a low-cost, low-side effects therapy for disseminated infections like HIV and multidrug-resistant TB. In fact, circumstantial evidence and logic suggest that such a therapy exists. But, for perverse reasons, it has never been properly tested. That therapy is Biophotonic Therapy, which can be administered to the blood extracorporeally with various kinds of light or intravenously with a low-intensity laser. BT has an excellent track record as a treatment of viral disorders ranging from bulbar spinal poliomyelitis to chronic hepatitis. Invented in the United States in the 1920s, BT has been used extensively in Germany and Russia, but not in any clinical trial against HIV or MDR-TB.
Biophotonic Therapy, however, is not the only approach that calls out for testing against HIV, MDR-TB, and other disseminated infections. Another candidate is Magnetized Water Therapy.